Skip to main content

News Releases

Menu
Press Release RSS Feed (opens in new window)
Press release year list 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
December 19, 2016
ADDING MULTIMEDIA and CONFERENCE CALL DETAILS Clovis Oncology Announces FDA Accelerated Approval of RUBRACA™ (rucaparib) for the Monotherapy Treatment of Advanced Ovarian Cancer in Women with Deleterious Germline or Somatic BRCA Mutations... Download PDF format download (opens in new window)
December 19, 2016
Clovis Oncology Announces FDA Accelerated Approval of RUBRACA™ (rucaparib) for the Monotherapy Treatment of Advanced Ovarian Cancer in Women with Deleterious Germline or Somatic BRCA Mutations Treated with Two or More Chemotherapies Download PDF format download (opens in new window)
November 3, 2016
Clovis Oncology Announces Q3 2016 Operating Results and Corporate Update Download PDF format download (opens in new window)
October 31, 2016
Clovis Oncology to Present at the 2016 Credit Suisse Healthcare Conference Download PDF format download (opens in new window)
October 27, 2016
Clovis Oncology to Announce Third Quarter 2016 Financial Results and Host Webcast Conference Call on November 3 Download PDF format download (opens in new window)
October 7, 2016
Clovis Oncology Presents Efficacy and Safety Data from New Drug Application (NDA) Population for Rucaparib in the Treatment of Advanced Mutant BRCA Ovarian Cancer at 2016 ESMO Congress Download PDF format download (opens in new window)
September 28, 2016
Clovis Oncology Announces Rucaparib Data Presentations at ESMO 2016 Congress Download PDF format download (opens in new window)
August 23, 2016
FDA Accepts Clovis Oncology’s New Drug Application for Rucaparib for Priority Review for the Treatment of Advanced Mutant BRCA Ovarian Cancer Download PDF format download (opens in new window)
August 8, 2016
Clovis Oncology Announces Q2 2016 Operating Results and Corporate Update Download PDF format download (opens in new window)
July 26, 2016
Clovis Oncology to Announce Second Quarter 2016 Financial Results and Host Webcast Conference Call on August 8 Download PDF format download (opens in new window)
June 6, 2016
Clovis Oncology Presents Data from Phase 2 Studies of Rucaparib in Advanced Ovarian Cancer and Pancreatic Cancer at 2016 ASCO Annual Meeting Download PDF format download (opens in new window)
May 19, 2016
Clovis Oncology Announces Data Presentations at 2016 ASCO Annual Meeting Download PDF format download (opens in new window)
May 5, 2016
Clovis Oncology Announces Q1 2016 Operating Results and Corporate Update Download PDF format download (opens in new window)
April 26, 2016
Clovis Oncology to Announce First Quarter 2016 Financial Results and Host Webcast Conference Call on May 5 Download PDF format download (opens in new window)
April 12, 2016
Clovis Oncology Provides Update on FDA Oncologic Drugs Advisory Committee Meeting to Review Rociletinib for Treatment of Advanced T790M-Positive Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer Download PDF format download (opens in new window)
April 12, 2016
Trading of Clovis Oncology, Inc. Common Stock Halted Download PDF format download (opens in new window)
April 8, 2016
FDA Posts Briefing Documents for Advisory Committee Meeting to Review Clovis Oncology’s Rociletinib for Treatment of Advanced T790M-Positive Mutant Epidermal Growth Factor Receptor Non-Small Cell Lung Cancer Download PDF format download (opens in new window)
February 25, 2016
Clovis Oncology Announces 2015 Operating Results Download PDF format download (opens in new window)
February 16, 2016
Clovis Oncology to Announce Fourth Quarter/Year-End 2015 Financial Results and Host Webcast Conference Call on February 25 Download PDF format download (opens in new window)
February 12, 2016
Clovis Oncology Announces Rociletinib New Drug Application Scheduled for Presentation at Upcoming FDA Oncologic Drugs Advisory Committee Meeting Download PDF format download (opens in new window)
January 27, 2016
Clovis Oncology Initiates Immunotherapy Combination Trial
January 25, 2016
Clovis Oncology Appoints Dale Hooks as Chief Commercial Officer Download PDF format download (opens in new window)
January 6, 2016
Clovis Oncology to Present at the 34th Annual J.P. Morgan Healthcare Conference Download PDF format download (opens in new window)